NCT04324840 2024-07-26
A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma
Celgene
Phase 1 Terminated
Celgene
Carr, Brian
King Faisal Specialist Hospital & Research Center
Merck KGaA, Darmstadt, Germany
Sanofi